Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1,001 - 1,050 out of 11,840

Document Document Title
WO/2007/056469A3
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.  
WO/2007/055929A1
Polyfunctional cyclic carbonates provide a useful additional monomer for energy-initiated cationic copolymerisation with such other monomers and oligomers as epoxides and oxetanes.  
WO/2007/056469A2
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.  
WO/2007/052843A1
Disclosed is a FXR inhibitor comprising a compound represented by the formula (I') or a salt or a prodrug of the compound or salt: wherein each symbol is as defined in the description. The FXR inhibitor has an excellent FXR-inhibiting ef...  
WO/2007/048595A1
The present invention relates to compounds of formula (I) comprising a lactam or a lactam derivative moiety, processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as pharmaceuticals.  
WO/2007/047306A1
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal depositi...  
WO/2007/042816A1
There is provided the use of a compound of formula (I),wherein Y, W1 to W4, Z1 to Z4 and R have meanings given in the description, and pharmaceutically-acceptable salts thereof, for the manufacture of a medicament for the treatment of a ...  
WO/2007/043400A1
Disclosed are: a novel compound having one or both of a xanthine oxidase inhibitory activity and an uric acid excretion promoting activity; a pharmaceutical composition comprising the compound as an active ingredient; use of the compound...  
WO/2007/044565A3
The present invention provides compounds and compositions for inhibiting Vif and methods for treating viral infection, e.g., HIV infection.  
WO/2007/043401A1
Disclosed are: a novel compound having a xanthine oxidase inhibitory activity and an uric acid excretion promoting activity; and a pharmaceutical composition comprising the compound as an active ingredient. The compound is a nitrogenated...  
WO/2007/037010A1
It is intended to provide a novel compound having an excellent agonism to PPARs α/γ and desirable properties as a drug. An agonist to peroxisome proliferator-activated receptors α/γ which is represented by the general formula (I) (wh...  
WO/2007/037187A1
A sulfonamide derivative having DP receptor antagonistic activity; and a medicinal composition and a therapeutic agent for allergic diseases which each contains the compound as an active ingredient. The derivative is a compound represent...  
WO/2007/034251A1
The present invention relates to the CCR3 receptor ligands of the general formula (I), within them favourably to antagonists and to the salts, solvates and isomers thereof, to the pharmaceutical compositions containing them, to the use o...  
WO/2007/034254A3
The present invention relates to the CCR3 receptor ligands of the general formula (I), within them favourably to antagonists and to the salts, solvates and isomers thereof, to the pharmaceutical compositions containing them, to the use o...  
WO/2007/034254A2
The present invention relates to the CCR3 receptor ligands of the general formula (I), within them favourably to antagonists and to the salts, solvates and isomers thereof, to the pharmaceutical compositions containing them, to the use o...  
WO/2007/034035A1
The invention relates to sulphonamide derivatives of formula (I), where Rc is selected from a group consisting of dialkylamino, NO2, CN, aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl, alkanoyl, oxazol-2-yl, oxazolylaminocar...  
WO/2007/032028A1
The present invention encompasses; the novel substituted heterocyclic compounds represented by formula (I) or their pharmaceutically acceptable salts, wherein the substituents in formula (I) have the meanings as defined in the specificat...  
WO/2007/033002A1
The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: (F) where the definitions of the variables Q, L1, , L2, M, X, L3, and A are provided ...  
WO/2007/030385A2
An improved method of preparing oxazolidine protected aminodiol compounds is disclosed. These compounds are useful intermediates in processes for making Florfenicol.  
WO2006106437A8
The present invention relates to novel compounds selected from substituted oxazole derivatives of formula (I) that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant tyrosine kinas...  
WO/2007/030386A2
An improved method of preparing oxazolidine protected aminodiol compounds is disclosed. These compounds are useful intermediates in processes for making Florfenicol.  
WO/2007/030385A3
An improved method of preparing oxazolidine protected aminodiol compounds is disclosed. These compounds are useful intermediates in processes for making Florfenicol.  
WO/2007/029036A3
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or stereoisomers thereof. The compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful for treating cel...  
WO/2007/030386A3
An improved method of preparing oxazolidine protected aminodiol compounds is disclosed. These compounds are useful intermediates in processes for making Florfenicol.  
WO/2007/029036A2
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or stereoisomers thereof. The compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful for treating cel...  
WO/2007/025709A2
The invention relates to novel diamines of the formula (I) in which all variables are as defined in the specification, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments ...  
WO/2007/026753A1
Disclosed is a method for producing a 2-oxazoline analogue or a 1,3-oxazine analogue represented by the general formula (3) below wherein 1,2-aminoalcohol or 1,2-aminothiol is reacted with α,α-dihaloamine. (3) (In the formula, n is 0 o...  
WO/2007/025709A3
The invention relates to novel diamines of the formula (I) in which all variables are as defined in the specification, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments ...  
WO/2007/023141A1
The present invention relates to N-oxides of certain piperazine and piperidine derivatives and to methods for the preparation of these compounds. The invention also relates to the use of compounds disclosed herein for the manufacture of ...  
WO/2007/020936A1
It is intended to provide a 1,6-β-glucan synthase inhibitor which strongly inhibits proliferation and has a high safety. It is intended to provide a compound which can specifically or selectively expressing an antifungal action on a bro...  
WO/2007/017687A2
A compound of formula (III): or a salt, solvate and chemically protected form thereof, wherein: R5 is an optionally substituted C5-20 aryl or C4-20 alkyl group; L' is a single bond, -O- or -C(=O)-; A is selected from the group consisting...  
WO/2007/017414A1
Dicyanoalkane compounds of formula (I), wherein R1, R2, R3,R4 and A are defined as in the description, or the enantiomers or diastereomers or salts thereof are subject matter of the present invention. Further also processes and intermedi...  
WO/2007/017546A2
The invention relates to a method of obtaining tryptamine derivatives (I), wherein R is a radical of a heterocycle, comprising the decarboxylation of the corresponding derivative of 3-(2-aminoethyl)-1H-indole carboxylic acid and the subs...  
WO/2007/019080A3
The present invention is directed to tricyclic compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The ...  
WO/2007/017669A1
Compounds of formula (I) are useful in the treatment of diseases where enhanced M3 receptor activation is implicated, such as respiritory tract diseases: wherein (i) R1 is C1-C6-alkyl or hydrogen; and R2 is hydrogen or a group -R7, -Z-Y-...  
WO/2007/017687A3
A compound of formula (III): or a salt, solvate and chemically protected form thereof, wherein: R5 is an optionally substituted C5-20 aryl or C4-20 alkyl group; L' is a single bond, -O- or -C(=O)-; A is selected from the group consisting...  
WO/2007/016979A2
The present invention relates to compounds of the general formula (III) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof, Formula (III) wherein R3 is H...  
WO2005123703A8
The present invention relates to novel compounds of formula (I) wherein W, n, X and W' are defined in the description; invention compounds are modulators of metabotropic glutamate receptors - subtype 5 ("mGluR5") which are useful for the...  
WO/2007/017546A3
The invention relates to a method of obtaining tryptamine derivatives (I), wherein R is a radical of a heterocycle, comprising the decarboxylation of the corresponding derivative of 3-(2-aminoethyl)-1H-indole carboxylic acid and the subs...  
WO/2007/016979A3
The present invention relates to compounds of the general formula (III) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof, Formula (III) wherein R3 is H...  
WO2006021420B1
The invention relates to a method for producing diarylcycloalkyl derivatives of general formula (I), wherein the radicals have the indicated meanings. The invention further relates to novel intermediate products that are formed by means ...  
WO/2007/015809A3
Compounds having the structure: are HIV reverse transcriptase inhibitors, wherein A, X, Y, Z, R1 and R2 are defined herein. The compounds and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcripta...  
WO2006069811B1
Compounds of Formula (4) or (5) that absorb ultraviolet light 380 nm to 400 nm range but avoid absorption in the blue light range, thereby imparting yellowness, i.e., 410-420 nm: have suitable refractive characteristics useful in the pre...  
WO/2007/015533A1
Disclosed is a novel amidine compound which can serve as an active ingredient of a highly safe herbicide which shows a reliable effect at a low dose. Also disclosed is a herbicide comprising the compound as an active ingredient. An amidi...  
WO/2007/013694A1
A compound represented by the general formula (I): (I) wherein each symbol is as defined in the description. The compound is excellent in the effect of decreasing the blood glucose level and the blood lipid level, and therefore is useful...  
WO/2007/014023A1
The present invention relates to certain single-enantiomer pyrrazol-4-yl derivatives of thiazolidinones, oxazolidinones, and pyrrolidinones which are useful in the treatment of Hepatitis B virus.  
WO/2007/014290A3
This invention is directed to compounds of Formula (1) including all geometric and stereoisomers, N oxides, and agriculturally suitable salts thereof, agricultural compositions containing them and their use as fungicides, (1) provided th...  
WO/2007/009389A3
The present invention provides compounds of formula (I), the preparation thereof and their use as peroxisome proliferator activated receptor-γ (PPAR-γ) agonist in the treatment of diabetes and diabetic complications.  
WO/2007/010653A1
A salt molten at room temperature that does not contain any organic solvent, excelling in stability; and a display device that is improved in the durability in high-temperature environment by virtue of the use thereof. There is provided ...  
WO/2007/009389A2
The present invention provides compounds of formula (I), the preparation thereof and their use as peroxisome proliferator activated receptor-γ (PPAR-γ) agonist in the treatment of diabetes and diabetic complications.  

Matches 1,001 - 1,050 out of 11,840